Stay updated on Comparing Antiviral Drugs in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.

Latest updates to the Comparing Antiviral Drugs in COVID-19 Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag was updated to v3.6.1, signaling a minor maintenance update to the document/versioning shown on the page.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page's metadata now includes the contact Andreas Barratt-Due and new verification fields (Last verified, Last known status was, No) along with FDA-regulated device/drug status indicators, and the revision is updated to v3.6.0. The previous lines for Last known status was: Verified, Andreas Barratt-Due, Oslo University Hospital, Not provided, and Revision: v3.5.5 have been removed.SummaryDifference1%

- Check23 days agoChange DetectedThe page footer now shows revision v3.5.5 instead of v3.5.4, indicating a backend update. No trial details or visible features were changed.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated to v3.5.4, signaling a new version of the page has been published. This typically reflects minor edits or maintenance to the page metadata.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision was updated to v3.5.3, replacing the previous v3.5.2. This indicates a version update of the study record.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s displayed system/API revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Comparing Antiviral Drugs in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.